facebook-pixel

Only COVID-19 patients scored as high risk will get popular monoclonal antibody treatment at new Utah center

New center increases access to the care in Utah — but experts warn treatment is not an alternative to vaccines.

(Chris Samuels | The Salt Lake Tribune) A new treatment center for monoclonal antibodies is shown to media, Thursday, Sept. 23, 2021, in Murray. The Utah Department of Health, which will operate the facility, will treatment high-risk patients sick with COVID-19 and provide infusions for up to 50 people per day.